[citation needed] Friedrich Weleminsky enrolled in the medical faculty of the German University in Prague in 1893 and obtained a habilitation qualification as Dr.Med.

While stationed in Kleinreifling, a village in the district of Steyr-Land in Upper Austria, he successfully brought a local typhoid epidemic under control, for which he was made an Ehrenbürger of Weyer.

In 1935, an editorial in the American Journal of Clinical Pathology cited one of his articles[5] as providing "a good review of the voluminous literature accumulated on BCG".

[6] In 1912 Weleminsky, who was then second assistant to Ferdinand Hueppe, the head of the Institute for Hygiene at the German University of Prague, published his discovery of a new treatment for tuberculosis, which he named tuberculomucin (Tbm).

[7][note 2] In 1938, Sanders, a Belgian pharmaceutical company, planned to manufacture Tbm and to make it available in Western Europe and other parts of the developed world.

[note 3] The married couple lived in Prague and at Schloss Thalheim,[1] which Jenny inherited from her father after his death in 1918 and which they ran as a model dairy farm.